ChartMill assigns a Buy % Consensus number of 83% to INDP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-13 | Maxim Group | Maintains | Buy -> Buy |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-20 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-08 | HC Wainwright & Co. | Reiterate | Overweight |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-10-19 | Maxim Group | Upgrade | Hold -> Buy |
7 analysts have analysed INDP and the average price target is 10.2 USD. This implies a price increase of 363.64% is expected in the next year compared to the current price of 2.2.
The consensus rating for INDAPTUS THERAPEUTICS INC (INDP) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering INDAPTUS THERAPEUTICS INC (INDP) is 7.